PTPRG and colorectal cancer: Similarly, in colorectal cancer the identification of somatic mutations suggests a complex scenario where PTPRG can be modified quantitatively (reduced expression driven by methylation/non-coding RNAs) and qualitatively (somatic mutations), a feature shared with the alteration of other classic TSGs in cancer development.